282 related articles for article (PubMed ID: 31767951)
1. PIC&RUN: An integrated assay for the detection and retrieval of single viable circulating tumor cells.
Kamal M; Saremi S; Klotz R; Iriondo O; Amzaleg Y; Chairez Y; Tulpule V; Lang JE; Kang I; Yu M
Sci Rep; 2019 Nov; 9(1):17470. PubMed ID: 31767951
[TBL] [Abstract][Full Text] [Related]
2. RareCyte® CTC Analysis Step 1: AccuCyte® Sample Preparation for the Comprehensive Recovery of Nucleated Cells from Whole Blood.
Ramirez AB; U'Ren L; Campton DE; Stewart D; Nordberg JJ; Stilwell JL; Kaldjian EP
Methods Mol Biol; 2017; 1634():163-172. PubMed ID: 28819849
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis.
Ramirez AB; Bhat R; Sahay D; De Angelis C; Thangavel H; Hedayatpour S; Dobrolecki LE; Nardone A; Giuliano M; Nagi C; Rimawi M; Osborne CK; Lewis MT; Stilwell JL; Kaldjian EP; Schiff R; Trivedi MV
BMC Cancer; 2019 Mar; 19(1):220. PubMed ID: 30871481
[TBL] [Abstract][Full Text] [Related]
4. Analogous detection of circulating tumor cells using the AccuCyte
van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
[TBL] [Abstract][Full Text] [Related]
5. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
[TBL] [Abstract][Full Text] [Related]
6. RareCyte
Stilwell JL; Varshavskaya P; Werbin JL; Nordberg JJ; Ramirez AB; Quarre S; Tzucker J; Chow J; Enright B; Kaldjian EP
Methods Mol Biol; 2017; 1634():181-192. PubMed ID: 28819851
[TBL] [Abstract][Full Text] [Related]
7. An integrated microfluidic chip system for single-cell secretion profiling of rare circulating tumor cells.
Deng Y; Zhang Y; Sun S; Wang Z; Wang M; Yu B; Czajkowsky DM; Liu B; Li Y; Wei W; Shi Q
Sci Rep; 2014 Dec; 4():7499. PubMed ID: 25511131
[TBL] [Abstract][Full Text] [Related]
8. High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining.
Campton DE; Ramirez AB; Nordberg JJ; Drovetto N; Clein AC; Varshavskaya P; Friemel BH; Quarre S; Breman A; Dorschner M; Blau S; Blau CA; Sabath DE; Stilwell JL; Kaldjian EP
BMC Cancer; 2015 May; 15():360. PubMed ID: 25944336
[TBL] [Abstract][Full Text] [Related]
9. The RareCyte® platform for next-generation analysis of circulating tumor cells.
Kaldjian EP; Ramirez AB; Sun Y; Campton DE; Werbin JL; Varshavskaya P; Quarre S; George T; Madan A; Blau CA; Seubert R
Cytometry A; 2018 Dec; 93(12):1220-1225. PubMed ID: 30277660
[TBL] [Abstract][Full Text] [Related]
10. Automated rare single cell picking with the ALS cellcelector™.
Nelep C; Eberhardt J
Cytometry A; 2018 Dec; 93(12):1267-1270. PubMed ID: 30184320
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer.
Wang Y; Guo L; Feng L; Zhang W; Xiao T; Di X; Chen G; Zhang K
Oncol Rep; 2018 May; 39(5):2147-2159. PubMed ID: 29565466
[TBL] [Abstract][Full Text] [Related]
13. An integrated enrichment system to facilitate isolation and molecular characterization of single cancer cells from whole blood.
Yu L; Sa S; Wang L; Dulmage K; Bhagwat N; Yee SS; Sen M; Pletcher CH; Moore JS; Saksena S; Dixon EP; Carpenter EL
Cytometry A; 2018 Dec; 93(12):1226-1233. PubMed ID: 30549400
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
15. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
Fujii T; Reuben JM; Huo L; Espinosa Fernandez JR; Gong Y; Krupa R; Suraneni MV; Graf RP; Lee J; Greene S; Rodriguez A; Dugan L; Louw J; Lim B; Barcenas CH; Marx AN; Tripathy D; Wang Y; Landers M; Dittamore R; Ueno NT
PLoS One; 2017; 12(9):e0185231. PubMed ID: 28957377
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell Phenotypic Profiling of CTCs in Whole Blood Using an Integrated Microfluidic Device.
Pei H; Li L; Wang Y; Sheng R; Wang Y; Xie S; Shui L; Si H; Tang B
Anal Chem; 2019 Sep; 91(17):11078-11084. PubMed ID: 31373191
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of circulating tumor cells-from bench to bedside.
Li Y; Wu S; Bai F
Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
[TBL] [Abstract][Full Text] [Related]
19. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
[TBL] [Abstract][Full Text] [Related]
20. The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer.
Dong L; Zhang Z; Smith K; Kuczler MD; Reyes D; Amend SR; Cho YK; Xue W; Pienta KJ
BJU Int; 2020 Jul; 126(1):191-201. PubMed ID: 32115854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
